• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高级别浆液性卵巢癌中的信号转导通路活性揭示:PI3K通路活性低且NF-κB通路活性高的肿瘤预后更有利——解决一个长期谜团的新方法

Signal Transduction Pathway Activity in High-Grade, Serous Ovarian Carcinoma Reveals a More Favorable Prognosis in Tumors with Low PI3K and High NF-κB Pathway Activity: A Novel Approach to a Long-Standing Enigma.

作者信息

van Lieshout Laura, van de Stolpe Anja, van der Ploeg Phyllis, Bowtell David, de Hullu Joanne, Piek Jurgen

机构信息

Department of Obstetrics and Gynecology, Catharina Cancer Institute, Catharina Hospital, 5602ZA Eindhoven, The Netherlands.

Radboud Institute for Health Sciences, Department of Obstetrics and Gynecology, Radboud University Medical Center, 6500HB Nijmegen, The Netherlands.

出版信息

Cancers (Basel). 2020 Sep 18;12(9):2660. doi: 10.3390/cancers12092660.

DOI:10.3390/cancers12092660
PMID:32961868
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7564278/
Abstract

We investigated signal transduction pathway (STP) activity in high-grade serous ovarian carcinoma (HGSC) in relation to progression-free survival (PFS) and overall survival (OS). We made use of signal transduction pathway activity analysis (STA analysis), a novel method to quantify functional STP activity. Activity of the following pathways was measured: androgen receptor (AR), estrogen receptor (ER), phosphoinositide 3-kinase (PI3K), Hedgehog (Hh), Notch, nuclear factor-kappa B (NF-κB), transforming growth factor beta (TGF-β), and Wnt. We selected HGSC samples from publicly available datasets of ovarian cancer tissue, and used repeated -means clustering to identify pathway activity clusters. PFS and OS of the clusters were analyzed. We used a subset of publicly available dataset GSE9891 ( = 140), where repeated -means clustering based on PI3K and NF-κB pathway activity in HGSC samples resulted in two stable clusters. The cluster with low PI3K and high NF-κB pathway activity ( = 72) had a more favorable prognosis for both PFS ( = 0.004) and OS ( = 0.001) compared to the high-PI3K and low-NF-κB pathway activity cluster ( = 68). The low PI3K and high NF-κB pathway activity of the favorable prognosis cluster may indicate a more active immune response, while the high PI3K and low NF-κB pathway activity of the unfavorable prognosis cluster may indicate high cell division.

摘要

我们研究了高级别浆液性卵巢癌(HGSC)中信号转导通路(STP)活性与无进展生存期(PFS)和总生存期(OS)的关系。我们采用了信号转导通路活性分析(STA分析),这是一种量化功能性STP活性的新方法。测量了以下通路的活性:雄激素受体(AR)、雌激素受体(ER)、磷酸肌醇3激酶(PI3K)、刺猬信号通路(Hh)、Notch、核因子κB(NF-κB)、转化生长因子β(TGF-β)和Wnt。我们从公开可用的卵巢癌组织数据集中选择HGSC样本,并使用重复均值聚类来识别通路活性簇。分析了这些簇的PFS和OS。我们使用了公开可用数据集GSE9891的一个子集(n = 140),其中基于HGSC样本中PI3K和NF-κB通路活性的重复均值聚类产生了两个稳定的簇。与高PI3K和低NF-κB通路活性簇(n = 68)相比,PI3K低且NF-κB通路活性高的簇(n = 72)在PFS(P = 0.004)和OS(P = 0.001)方面预后更优。预后良好簇的低PI3K和高NF-κB通路活性可能表明免疫反应更活跃,而预后不良簇的高PI3K和低NF-κB通路活性可能表明细胞分裂活跃。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/262e/7564278/8c6d0ec79750/cancers-12-02660-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/262e/7564278/90915d84267f/cancers-12-02660-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/262e/7564278/61123c610d20/cancers-12-02660-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/262e/7564278/a17d4ec18782/cancers-12-02660-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/262e/7564278/8c6d0ec79750/cancers-12-02660-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/262e/7564278/90915d84267f/cancers-12-02660-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/262e/7564278/61123c610d20/cancers-12-02660-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/262e/7564278/a17d4ec18782/cancers-12-02660-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/262e/7564278/8c6d0ec79750/cancers-12-02660-g004.jpg

相似文献

1
Signal Transduction Pathway Activity in High-Grade, Serous Ovarian Carcinoma Reveals a More Favorable Prognosis in Tumors with Low PI3K and High NF-κB Pathway Activity: A Novel Approach to a Long-Standing Enigma.高级别浆液性卵巢癌中的信号转导通路活性揭示:PI3K通路活性低且NF-κB通路活性高的肿瘤预后更有利——解决一个长期谜团的新方法
Cancers (Basel). 2020 Sep 18;12(9):2660. doi: 10.3390/cancers12092660.
2
Survival Is Related to Estrogen Signal Transduction Pathway Activity in Postmenopausal Women Diagnosed with High-Grade Serous Ovarian Carcinoma.生存与诊断为高级别浆液性卵巢癌的绝经后女性的雌激素信号转导通路活性相关。
Cancers (Basel). 2021 Oct 12;13(20):5101. doi: 10.3390/cancers13205101.
3
Immunostaining Study on the Expression of NF-κB, ER, and PR in Ovarian Serous Carcinoma.卵巢浆液性癌中NF-κB、雌激素受体和孕激素受体表达的免疫染色研究
Int J Gynecol Pathol. 2017 Jan;36(1):58-63. doi: 10.1097/PGP.0000000000000297.
4
Prognostic impact of HER3 based on protein and mRNA expression in high-grade serous ovarian carcinoma.基于蛋白质和mRNA表达的HER3在高级别浆液性卵巢癌中的预后影响
Virchows Arch. 2017 Feb;470(2):143-151. doi: 10.1007/s00428-016-2050-6. Epub 2016 Dec 2.
5
NF-κB participates in chemokine receptor 7-mediated cell survival in metastatic squamous cell carcinoma of the head and neck.NF-κB 参与趋化因子受体 7 介导的头颈部转移性鳞状细胞癌中的细胞存活。
Oncol Rep. 2011 Feb;25(2):383-91. doi: 10.3892/or.2010.1090. Epub 2010 Dec 9.
6
Transforming growth factor-beta1 stimulates heme oxygenase-1 expression via the PI3K/Akt and NF-kappaB pathways in human lung epithelial cells.转化生长因子-β1通过PI3K/Akt和NF-κB信号通路刺激人肺上皮细胞中血红素加氧酶-1的表达。
Eur J Pharmacol. 2007 Apr 10;560(2-3):101-9. doi: 10.1016/j.ejphar.2007.01.025. Epub 2007 Jan 27.
7
γ-Glutamyl cyclotransferase contributes to tumor progression in high grade serous ovarian cancer by regulating epithelial-mesenchymal transition via activating PI3K/AKT/mTOR pathway.γ-谷氨酰环转移酶通过激活 PI3K/AKT/mTOR 通路调节上皮-间充质转化促进高级别浆液性卵巢癌的进展。
Gynecol Oncol. 2018 Apr;149(1):163-172. doi: 10.1016/j.ygyno.2018.01.023. Epub 2018 Feb 9.
8
Inhibition of nuclear factor-kappa B enhances the tumor growth of ovarian cancer cell line derived from a low-grade papillary serous carcinoma in p53-independent pathway.核因子-κB的抑制通过p53非依赖途径增强了源自低级别乳头状浆液性癌的卵巢癌细胞系的肿瘤生长。
BMC Cancer. 2016 Aug 2;16:582. doi: 10.1186/s12885-016-2617-2.
9
[Effects of PI3K/Akt/NF-κB signal pathway on FSH facilitation on cell proliferation and invasion by human epithelial ovarian cancer].[PI3K/Akt/NF-κB信号通路对促卵泡生成素促进人上皮性卵巢癌细胞增殖和侵袭的影响]
Zhonghua Fu Chan Ke Za Zhi. 2012 Feb;47(2):134-8.
10
Expression of p52, a non-canonical NF-kappaB transcription factor, is associated with poor ovarian cancer prognosis.非经典核因子-κB转录因子p52的表达与卵巢癌预后不良相关。
Biomark Res. 2020 Sep 15;8:45. doi: 10.1186/s40364-020-00227-y. eCollection 2020.

引用本文的文献

1
Patient-Representative Cell Line Models in a Heterogeneous Disease: Comparison of Signaling Transduction Pathway Activity Between Ovarian Cancer Cell Lines and Ovarian Cancer.异质性疾病中的患者代表性细胞系模型:卵巢癌细胞系与卵巢癌之间信号转导通路活性的比较
Cancers (Basel). 2024 Dec 2;16(23):4041. doi: 10.3390/cancers16234041.
2
Exploring the relation between TGF-β pathway activity and response to checkpoint inhibition in patients with metastatic melanoma.探索转移性黑色素瘤患者中转化生长因子-β(TGF-β)信号通路活性与免疫检查点抑制反应之间的关系。
Clin Exp Immunol. 2025 Jan 21;219(1). doi: 10.1093/cei/uxae108.
3
Phenotype-guided targeted therapy based on functional signal transduction pathway activity in recurrent ovarian cancer patients: The STAPOVER study protocol.

本文引用的文献

1
Oestrogen receptor pathway activity is associated with outcome in endometrial cancer.雌激素受体通路活性与子宫内膜癌的预后相关。
Br J Cancer. 2020 Sep;123(5):785-792. doi: 10.1038/s41416-020-0925-4. Epub 2020 Jun 8.
2
Targeting the PI3K/AKT/mTOR/NFκB Axis in Ovarian Cancer.靶向卵巢癌中的PI3K/AKT/mTOR/NFκB信号轴
J Cell Immunol. 2020;2(2):68-73. doi: 10.33696/immunology.1.022.
3
Stable expansion of high-grade serous ovarian cancer organoids requires a low-Wnt environment.高等级浆液性卵巢癌细胞类器官的稳定扩增需要低 Wnt 环境。
基于复发性卵巢癌患者功能信号转导通路活性的表型导向靶向治疗:STAPOVER研究方案。
Heliyon. 2023 Dec 1;10(1):e23170. doi: 10.1016/j.heliyon.2023.e23170. eCollection 2024 Jan 15.
4
"DEPHENCE" system-a novel regimen of therapy that is urgently needed in the high-grade serous ovarian cancer-a focus on anti-cancer stem cell and anti-tumor microenvironment targeted therapies.“DEPHENCE”系统——一种高级别浆液性卵巢癌迫切需要的新型治疗方案——聚焦于抗癌干细胞和抗肿瘤微环境靶向治疗。
Front Oncol. 2023 Jun 28;13:1201497. doi: 10.3389/fonc.2023.1201497. eCollection 2023.
5
The senescence-associated secretory phenotype in ovarian cancer dissemination.卵巢癌转移中的衰老相关分泌表型。
Am J Physiol Cell Physiol. 2022 Jul 1;323(1):C125-C132. doi: 10.1152/ajpcell.00049.2022. Epub 2022 May 18.
6
Survival Is Related to Estrogen Signal Transduction Pathway Activity in Postmenopausal Women Diagnosed with High-Grade Serous Ovarian Carcinoma.生存与诊断为高级别浆液性卵巢癌的绝经后女性的雌激素信号转导通路活性相关。
Cancers (Basel). 2021 Oct 12;13(20):5101. doi: 10.3390/cancers13205101.
7
Multiple Myeloma Relapse Is Associated with Increased NFκB Pathway Activity and Upregulation of the Pro-Survival BCL-2 Protein BFL-1.多发性骨髓瘤复发与核因子κB(NFκB)信号通路活性增加及促生存蛋白BCL-2家族成员BFL-1的上调有关。
Cancers (Basel). 2021 Sep 17;13(18):4668. doi: 10.3390/cancers13184668.
8
Predictive and Prognostic Biomarker Identification in a Large Cohort of Androgen Receptor-Positive Salivary Duct Carcinoma Patients Scheduled for Combined Androgen Blockade.在一大批计划接受联合雄激素阻断治疗的雄激素受体阳性涎腺导管癌患者中进行预测性和预后生物标志物的鉴定。
Cancers (Basel). 2021 Jul 14;13(14):3527. doi: 10.3390/cancers13143527.
9
RNA Based Approaches to Profile Oncogenic Pathways From Low Quantity Samples to Drive Precision Oncology Strategies.基于RNA的方法:从低量样本剖析致癌途径以推动精准肿瘤学策略
Front Genet. 2021 Feb 5;11:598118. doi: 10.3389/fgene.2020.598118. eCollection 2020.
EMBO J. 2020 Mar 16;39(6):e104013. doi: 10.15252/embj.2019104013. Epub 2020 Feb 3.
4
Estrogen Receptor Pathway Activity Score to Predict Clinical Response or Resistance to Neoadjuvant Endocrine Therapy in Primary Breast Cancer.雌激素受体通路活性评分预测原发性乳腺癌新辅助内分泌治疗的临床反应或耐药性。
Mol Cancer Ther. 2020 Feb;19(2):680-689. doi: 10.1158/1535-7163.MCT-19-0318. Epub 2019 Nov 14.
5
NF-κB Signaling in Ovarian Cancer.卵巢癌中的核因子-κB信号传导
Cancers (Basel). 2019 Aug 15;11(8):1182. doi: 10.3390/cancers11081182.
6
The Hedgehog Signaling Pathway: A Viable Target in Breast Cancer?刺猬信号通路:乳腺癌的一个可行靶点?
Cancers (Basel). 2019 Aug 7;11(8):1126. doi: 10.3390/cancers11081126.
7
Research progress on the PI3K/AKT signaling pathway in gynecological cancer (Review).妇科恶性肿瘤中 PI3K/AKT 信号通路的研究进展(综述)。
Mol Med Rep. 2019 Jun;19(6):4529-4535. doi: 10.3892/mmr.2019.10121. Epub 2019 Apr 3.
8
Quantitative Measurement of Functional Activity of the PI3K Signaling Pathway in Cancer.癌症中PI3K信号通路功能活性的定量测量
Cancers (Basel). 2019 Mar 1;11(3):293. doi: 10.3390/cancers11030293.
9
Targeting PI3K in cancer: mechanisms and advances in clinical trials.针对癌症的 PI3K 靶向治疗:机制与临床试验进展。
Mol Cancer. 2019 Feb 19;18(1):26. doi: 10.1186/s12943-019-0954-x.
10
Enabling precision medicine by unravelling disease pathophysiology: quantifying signal transduction pathway activity across cell and tissue types.通过揭示疾病病理生理学来实现精准医学:量化跨细胞和组织类型的信号转导途径活性。
Sci Rep. 2019 Feb 7;9(1):1603. doi: 10.1038/s41598-018-38179-x.